Professor Tom Borody of Sydney, Australia will present the results of over 20 years of research into an effective treatment for Crohn's Disease. He will deliver data from a clinical study of 213 patients in Australia along with the responses to treatment of over 50 of Prof. Borody's own patients, to his anti-mycobacteria therapy research.

According to Prof. Borody's report, as many as 95% of his patients have responded to treatment with full remission achieved by 65% of these patients. Dr. Borody says, "These results exceed all documented evidence of response to Crohn's Disease therapies and promise significant relief for a large number of the estimated one million Crohn's patients around the world."

Dr. Borody MD PhD FRACP, a graduate of the University of New South Wales, from which he holds a doctorate in medicine, will be presenting his findings in an open forum at:

The Suffolk Y Jewish Community Center
74 Hauppauge Road in Commack, Long Island
March 20, 2006 from 7-9 PM.
Suggested donation $3

As the founder and current Medical Director of the Centre for Digestive Diseases (CDD), Dr. Borody has created a unique medical institution, internationally regarded for its novel approaches in research, diagnosis and the treatment of gastrointestinal conditions. He has been a recipient of the Winthrop Traveling Fellowship, the Neil Hamilton Fairly Fellowship and the Marshall & Warren Prize, and was a Clinical Fellow in Gastroenterology at the Mayo Clinic in Rochester in 1983. He is a member of the Australian Medical Association, the Gastroenterological Society of Australia, the European Gastroenterology Society, the Functional Brain-Gut Research Group and Fellow of the American College of Gastroenterology and the American College of Physicians.

Prof. Borody supervises a number of major research programs as well as being involved as a reviewer for the American Journal of Gastroenterology, Digestive Diseases and Sciences, Endoscopy, Journal of Gastroenterology and Hepatology, Medical Journal of Australia and Digestive and Liver Diseases. He has published in excess of 120 scientific papers. In 2004 he was appointed an Adjunct Professor of the Faculty of Science at the University of Technology, Sydney.

The Suffolk Y JCC is an agency of UJA Federation and affiliated with JCC Association. Additional funding is provided by the United Way of Long Island and the Townwide Fund of Huntington. The Suffolk Y JCC takes no position on the efficacy of Dr. Borody's treatment.

http://www.syjcc.org